69. Musculoskeletal Cancer Surgery. Ed. by M. Malawer. Dordrecht: Springer, 2013. Pp. 583–593.
70. Committee NMA: The diagnosis and treatment of lymphedema. Position Statement of the National Lymphedema Network. 2011. 19 p.
71. Segal R., Zwaal C., Green E. et al. Exercise for People with Cancer Guideline Development G: Exercise for people with cancer: a systematic review. . Curr Oncol 2017;24(4):e290–315.
72. Boyd C., Crawford C., Paat C.F. et al. Evidence for Massage Therapy Working G: The impact of massage therapy on function in pain populations-a systematic review and meta-analysis of randomized controlled trials: Part II, Cancer pain populations. Pain Med 2016;17(8):1553–68.
73. Stout N.L., Baima J., Swisher A.K. et al. A systematic review of exercise systematic reviews in the cancer literature (2005–2017). PM R 2017;9(9S2):S347–84.
74. Fizazi, K., et al. Personalised chemotherapy based on tumour marker decline in poor prognosis germcell tumours (GETUG 13): a phase 3, multicentre, randomised trial. Lancet Oncol, 2014. 15: 1442.
75. Mustian K.M., Alfano C.M., Heckler C. et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol 2017;3(7):961–8.
76. Freeman Jodie, Klingele Anna, Wolf Ursula. Effectiveness of music therapy, aromatherapy, and massage therapy on people in palliative care with end-of-life needs: A systematic review. J Pain Symptom Manage. 2024 Aug 12:S0885-3924(24)00903-5.
77. Streckmann F., Zopf E.M., Lehmann H.C. et al. Exercise intervention studies in patients with peripheral neuropathy: a systematic review. Sports Med 2014;44(9):1289–304.
78. Kleckner I.R., Kamen C., Gewandter J.S. et al. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. . Support Care Cancer 2018;26(4):1019–28.
79. Lee J.M., Look R.M., Turner C. et al. Low-level laser therapy for chemotherapy-induced peripheral neuropathy. J Clin Oncol 2012;30(15 suppl):9019.
80. Rick O., von Hehn U., Mikus E. et al. Magnetic field therapy in patients with cytostatics-induced polyneuropathy: A prospective randomized placebo-controlled phase-III study. . Bioelectromagnetics 2017;38(2):85–94.
81. Kilinc M., Livanelioglu A., Yildirim S.A., Tan E. Effects of transcutaneous electrical nerve stimulation in patients with peripheral and central neuropathic pain. J Rehabil Med 2014;46(5):454–60.
82. Oberoi S., Zamperlini-Netto G., Beyene J. et al. Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS One 2014;9(9):e107418.
83. Westphal J.G., Schulze P.C. Exercise training in cancer related cardiomyopathy. J Thorac Dis 2018;10(Suppl35):S4391–9.
84. Ross M., Fischer-Cartlidge E. Scalp cooling: a literature review of efficacy, safety, and tolerability for chemotherapy-induced alopecia. Clin J Oncol Nurs 2017;21(2):226–33.
85. Rief H., Omlor G., Akbar M. et al. Feasibility of isometric spinal muscle training in patients with bone metastases under radiation therapy – first results of a randomized pilot trial. BMC Cancer 2014;14:6.
86. Bensadoun R.J., Nair R.G. Low-level laser therapy in the management of mucositis and dermatitis induced by cancer therapy. . Photomed Laser Surg 2015;33(10):487–91.
87. Temoshok L. Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology and tumor-host response. Soc Sci Med 1985;20(8):833–40.
88. Solveigh Paola Lingens, Georgia Schilling, Holger Schulz, and Christiane Bleich. Effectiveness of brief psychosocial support for patients with cancer and their relatives: a quasi-experimental evaluation of cancer counselling centres. BMJ Open. 2023; 13(3): e068963.
89. Lichtenthal W.G., Cruess D.G., Schuchter L.M., Ming M.E. Psychosocial factors related to the correspondence of recipient and provider perceptions of social support among patients diagnosed with or at risk for malignant melanoma. J Health Psychol 2003;8(6):705–19.
90. Sollner W., Zschocke I., Zingg-Schir M. et al. Interactive patterns of social support and individual coping strategies in melanoma patients and their correlations with adjustment to illness. Psychosomatics 1999;40(3):239–50.
91. Devine D., Parker P.A., Fouladi R.T., Cohen L. The association between social support, intrusive thoughts, avoidance, and adjustment following an experimental cancer treatment. . Psychooncology 2003;12(5):453–62.
92. Chovanec M., Abu Zaid M., Hanna N. et al. Long-term toxicity of cisplatin in germ-cell tumor survivors. Ann Oncol 2017;28(11):2670–9.
93. Трякин А.А., Бесова Н.С., Волков Н.М., Гладков О.А., Карасева В.В., Сакаева Д.Д. и соавт. Общие принципы проведения противоопухолевой лекарственной терапии. Практические рекомендации RUSSCO, часть 1. Злокачественные опухоли, 2023 (том 13), #3s2, стр. 28–41.
94. P Giannatempo, T Greco, L Mariani, et al. Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes. Ann Oncol . 2015 Apr;26(4):657-668. doi: 10.1093/annonc/mdu447.
95. Isamu Tachibana, Sean Q Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol . 2022 Nov 10;40(32):3762-3769. doi: 10.1200/JCO.22.00118
96. Axel Heidenreich, Pia Paffenholz, Florian Hartmann, et al. Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS). Eur Urol Oncol. 2024 Feb;7(1):122-127. doi: 10.1016/j.euo.2023.06.004.